Less is More: Benefit of Achieving Very Low Low-Density Lipoprotein-Cholesterol Levels on Cardiovascular Events
Journal Title: Heart Research – Open Journal - Year 2017, Vol 4, Issue 1
Abstract
Low-density lipoprotein-cholesterol (LDL-C) reduction with statin therapy is one of the most pivotal interventions for atherosclerotic cardiovascular disease (ASCVD) prevention and treatment. The risk of coronary artery disease (CAD) decreases with reduction in LDL-C but there is no established level at which the risk becomes insignificant. The current practice guidelines for the primary prevention of CAD recommends calculation of ASCVD risk instead of targeting a particular cholesterol level for initiating statin therapy.1,2 It is recommended that patients with known CAD or those presenting with acute coronary syndromes (ACS) receive high intensity statin independent of baseline LDL-C levels. However, the target LDL-C goal for secondary prevention of CAD remains unclear. Besides reducing LDL-C, statins also have pleiotropic effects, such as lowering inflammation and stabilizing atherosclerotic plaques.
Authors and Affiliations
Amber Fatima
Dimethyl Sulfoxide Reduces Microvascular Obstruction and Intramyocardial Hemorrhage in a Porcine Ischemia-Reperfusion Model
Background: Microvascular obstruction (MVO) and Intramyocardial hemorrhage (IMH) are associated with myocardial reperfusion injury and recognized as predictors of adverse left ventricular remodeling in acute myocardial i...
Autonomic Dysfunction, Sympathetic Hyperactivity and the Development of End-Organ Damage in Hypertension: Multiple Benefits of Exercise Training
Autonomic dysfunction is closely related to the development of hypertension, which is characterized by increased sympathetic activity, decreased vagal tonus and baroreflex dysfunction. The hypertension-induced maladaptiv...
The Challenge of Dysglycemia and Coronary Heart Disease
The prevalence of type 2 diabetes mellitus (T2DM) is increasing globally, and although there is a small increase in the incidence of type 1 diabetes mellitus, T2DM accounts for 95% of all individuals with diabetes.1 A h...
E-Care Project: A Promising E-Platform for Optimizing Management of Chronic Heart Failure and Other Chronic Diseases
Monitoring patients with heart failure by using telemedicine systems is a potential means for optimizing the management of these patients. The E-care project is developing an “intelligent” communicative platform enabling...
Biomarkers Score for Patients with Mitral Stenosis: A useful conjunction with Wilkins’s Score for Early Intervention
Objective: We proposed a novel new insight independent score of Mitral Stenosis (MS) based on elevated biomarkers. Subjects and Methods: One hundred sixty-eight patients with MS candidate for Percutanous balloon valvulop...